Similar sites
Category
N/AGlobal Rank
N/ARank in 1 month
0Estimate Value
N/A
#understand c
#scitools
#insyde software
#insyde software firmware
#insyde bios update
#insyde bios update lenovo
#insyde firmware
#scitools understand
#scientific toolworks understand
#emenda
#klocwork
#understand scitools
Category
N/AGlobal Rank
N/ARank in 1 month
0Estimate Value
N/A
#polyethylen opravy svařování
#ulození optickeho kabelu v zemi
#písemné dělení
#převody jednotek
#dělení dvojciferným číslem
#pozice fáze v zásuvce
#výpočet dostatečné vzdálenosti pomocného jímače
#zapojení tn-c na tn-s
#nehořlavé kabely lapp kabel
#krajský úřad olomouc
#zobrazení dutým zrcadlem příklady
#olomoucký kraj
#smyčkové proudy příklady
#uzavírky olomoucký kraj
#stanovení vnějších vlivů tičr
#připojení přes proudový chránič 30 ma.
#andragogika
#google scholar
#abstraktní myšlení
#kvantitativní výzkum
#scholar
#násobení dvojciferným číslem
#měrná tepelná kapacita
#tábor
#slovní druhy
#rozdělení kovů
Category
N/AGlobal Rank
N/ARank in 1 month
25.8KEstimate Value
N/A
#糖尿病 症状
#糖尿病
#低血糖
#低血糖 症状
#糖尿病 原因
#glp-1 肥満
#glp-1 肥満症
#glp-1 肥満治療
#sglt2阻害薬
#wegovy 肥満
#オルミエント
#ストラテラ
#サインバルタ
#トルリシティ
#リベルサス
#オゼンピック
#ビクトーザ
#novo nordisk
Malware Scan Info
Macafee Check :
Email address with emendobio.com
2. [email protected]
3. [email protected]
4. [email protected]
5. [email protected]
6. [email protected]
7. [email protected]
Recent Searched Sites
Igiani.com (1 mins ago) / US
Sos.powernet.com.ru (33 seconds ago) / RU
Student.tsul.uz (42 seconds ago) / UZ
Martharedbone.net (2 mins ago) / VG
Steakhousechile.com (1 seconds ago) / SG
Pardridge.com (23 seconds ago) / US
Powernet.com.ru (29 seconds ago) / RU
Drgabrielladesalvo.com (1 mins ago) / US
Emendobio.com (0 seconds ago) / US
Kakupress.com (1 mins ago) / GB
Shamblottfamilydentistry.com (30 seconds ago) / US
Press.tn.ru (1 mins ago) / RU
Kaska.pazaruvaj.com (4 seconds ago) / US
Shambhala-bed-and-breakfast-buckhorn.ibooked.ca (37 seconds ago) / US
Flymehigh.com (2 mins ago) / US
Amarcotte.com (1 mins ago) / CA
008884.com (16 seconds ago) / US
Shambhalaonline.org (1 seconds ago) / US
Kibrisgenctv.com (3 seconds ago) / US
Softfamed.com (1 mins ago) / US
Domain Informations
Emendobio.com lookup results from whois.godaddy.com server:
- Domain created: 2015-05-15T08:41:17Z
- Domain updated: 2022-10-30T04:35:36Z
- Domain expires: 2025-05-15T08:41:17Z 1 Year, 30 Days left
- Website age: 8 Years, 335 Days
- Registrar Domain ID: 1929098938_DOMAIN_COM-VRSN
- Registrar Url: http://www.godaddy.com
- Registrar WHOIS Server: whois.godaddy.com
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: 480-624-2505
- Name server:
- NS19.DOMAINCONTROL.COM
- NS20.DOMAINCONTROL.COM
Network
- inetnum : 34.64.0.0 - 34.127.255.255
- name : GOOGL-2
- handle : NET-34-64-0-0-1
- status : Direct Allocation
- created : 2006-09-29
- changed : 2019-11-01
- desc : *** The IP addresses under this Org-ID are in use by Google Cloud customers ***,Direct all copyright and legal complaints to,https://support.google.com/legal/go/report,Direct all spam and abuse complaints to,https://support.google.com/code/go/gce_abuse_report,For fastest response, use the relevant forms above.,Complaints can also be sent to the GC Abuse desk,([email protected]),but may have longer turnaround times.,Complaints sent to any other POC will be ignored.
Owner
- organization : Google LLC
- handle : GOOGL-2
- address : Array,Mountain View,CA,94043,US
Technical support
- handle : ZG39-ARIN
- name : Google LLC
- phone : +1-650-253-0000
- email : [email protected]
Abuse
- handle : GCABU-ARIN
- name : GC Abuse
- phone : +1-650-253-0000
- email : [email protected]
Domain Provider | Number Of Domains |
---|---|
godaddy.com | 680223 |
namecheap.com | 223695 |
networksolutions.com | 165349 |
tucows.com | 138518 |
publicdomainregistry.com | 89312 |
whois.godaddy.com | 62138 |
enomdomains.com | 58843 |
namesilo.com | 49234 |
cloudflare.com | 47031 |
gmo.jp | 46050 |
register.com | 39345 |
fastdomain.com | 38711 |
ionos.com | 33722 |
name.com | 32734 |
wildwestdomains.com | 32385 |
net.cn | 31518 |
registrar.amazon.com | 29951 |
key-systems.net | 27072 |
domains.google.com | 27061 |
Host Informations
Host name | 87.186.102.34.bc.googleusercontent.com |
IP address | 34.102.186.87 |
Location | United States |
Latitude | 37.751 |
Longitude | -97.822 |
Timezone | America/Chicago |
Port Scanner (IP: 34.102.186.87)
Spam Check (IP: 34.102.186.87) › Dnsbl-1.uceprotect.net:
› Dnsbl-2.uceprotect.net:
› Dnsbl-3.uceprotect.net:
› Dnsbl.dronebl.org:
› Dnsbl.sorbs.net:
› Spam.dnsbl.sorbs.net:
› Bl.spamcop.net:
› Recent.dnsbl.sorbs.net:
› All.spamrats.com:
› B.barracudacentral.org:
› Bl.blocklist.de:
› Bl.emailbasura.org:
› Bl.mailspike.org:
› Bl.spamcop.net:
› Cblplus.anti-spam.org.cn:
› Dnsbl.anticaptcha.net:
› Ip.v4bl.org:
› Fnrbl.fast.net:
› Dnsrbl.swinog.ch:
› Mail-abuse.blacklist.jippg.org:
› Singlebl.spamgrouper.com:
› Spam.abuse.ch:
› Spamsources.fabel.dk:
› Virbl.dnsbl.bit.nl:
› Cbl.abuseat.org:
› Dnsbl.justspam.org:
› Zen.spamhaus.org:
Site Inspections
Websites Listing
We found Websites Listing below when search with emendobio.com on Search Engine
Emendo Biotherapeutics | LinkedIn
Emendo biotherapeutics develops next generation gene editing tools for genetic disorders, addressing the current technological gaps for realizing the promise of gene therapy. We leverage our...
Linkedin.comDA: 16 PA: 30 MOZ Rank: 46
EmendoBio Gene Editing Company Acquired by AnGes, Inc.
EmendoBio is now an independent wholly-owned subsidiary of AnGes, and will continue to maintain its business operations at its facilities in New York, NY and Tel Aviv, Israel. The acquisition was ...
Businesswire.comDA: 20 PA: 50 MOZ Rank: 49
Emendo Biotherapeutics Email Formats & Employee Phones
39%. lastName.firstNameInitial. [email protected]. 80%. lastNameInitial-firstNameInitial. [email protected]. 67%. Overview. Emendo biotherapeutics develops next generation gene editing tools for genetic disorders, addressing the current technological gaps for realizing the promise of gene therapy.
Signalhire.comDA: 18 PA: 33 MOZ Rank: 53
AnGes, Inc.
2022.06.16 IR Notice Regarding Posting of Non-operating Income 2022.05.11 IR Eiger BioPharmaceuticals and AnGes Announce Exclusive Partnership for Regulatory Approval and Commercialization of Zokinvy® (lonafarnib) in Japan
Anges.co.jpDA: 15 PA: 4 MOZ Rank: 22
Emendo Biotherapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Emendo was set up to expand what is possible in genome editing. They believe that challenges can be overcome by fusing expertise in diverse disciplines, and by looking at the core questions with a new approach.
Crunchbase.comDA: 18 PA: 36 MOZ Rank: 58
Emendo Biotherapeutics - Start-Up Nation Finder
About. Emendo is developing genome-editing technology that can repair and eliminate genetic mutations in living cells that cause serious diseases or disorders. Emendo's gene-editing solutions are recombination based, highly specific, and …
Finder.startupnationcentral.orgDA: 31 PA: 36 MOZ Rank: 72
Emendo Biotherapeutics | CipherBio
EmendoBio Acquired by AnGes for $250M. 1/15/20. Investment. $61.0M. Emendo Biotherapeutics Raises $61M in Series B Led by AnGes Inc. and Joined by OrbiMed Advisors, OrbiMed Israel Partners, and Takeda Ventures. Created with Highcharts 9.2.2. Preclinical Preclinical Emendo Biotherapeutics Emendo Biotherapeutics Genetic Diseases Genetic …
Cipherbio.comDA: 17 PA: 45 MOZ Rank: 68
EmendoBio Gene Editing Company Acquired by AnGes, Inc.
EmendoBio is now an independent wholly-owned subsidiary of AnGes, and will continue to maintain its business operations at its facilities in New York, NY and Tel Aviv, Israel. The acquisition was completed on December 15, 2020. David Baram, Ph.D., President and Chief Executive Officer of EmendoBio, commented, “This transaction underscores the ...
Biospace.comDA: 16 PA: 50 MOZ Rank: 95
WIPO - 国際・国内特許データベース検索
This patent search tool allows you not only to search the PCT database of about 2 million International Applications but also the worldwide patent collections. This search facility features: flexible search syntax; automatic word stemming and relevance ranking; as …
Wipo.intDA: 12 PA: 33 MOZ Rank: 53
Emendo Biotherapeutics - Company Profile and News
Company profile page for Emendo Biotherapeutics including stock price, company news, press releases, executives, board members, and contact information
Bloomberg.comDA: 17 PA: 28 MOZ Rank: 54
Emendo Biotherapeutics and Seattle Children’s Research Institute ...
EmendoBio is a next generation CRISPR gene editing company leveraging dual proprietary technology platforms to enable high precision gene editing throughout the genome. EmendoBio’s novel ...
Finance.yahoo.comDA: 17 PA: 50 MOZ Rank: 96
Emendo Biotherapeutics Raises $61 Million to Advance Next …
NEW YORK--(BUSINESS WIRE)--Emendo Biotherapeutics, a leader in next-generation gene editing using synthetic biology to address untreatable diseases, today announced a Series B investment totaling ...
Businesswire.comDA: 20 PA: 50 MOZ Rank: 39
Emendobio Inc. Company Profile | New York, NY | Competitors, …
Company Description: Emendobio Inc. is located in New York, NY, United States and is part of the Scientific Research and Development Services Industry. Emendobio Inc. has 11 total employees across all of its locations and generates $523,924 in sales (USD). (Employees and Sales figures are modelled).
Dnb.comDA: 11 PA: 50 MOZ Rank: 38
Email & Phone of top management contacts - EasyLeadz
[email protected] ****453*** View Number: Similar Companies to Emendo Biotherapeutics. Name Industry Headquarters No of employees; Bratati Corporate Services Private Limited: Community, Personal & Social Services: Delhi, Delhi-Ale House Private Limited: Community, Personal & Social Services: Delhi, Delhi-Akshaya Pvt Ltd : Real Estate: Chennai,-Ensight …
Easyleadz.comDA: 17 PA: 31 MOZ Rank: 61
Emendo Biotherapeutics and Seattle Children’s Research ... - Yahoo!
EmendoBio is a next generation CRISPR gene editing company leveraging dual proprietary technology platforms to enable high precision gene editing throughout the genome. EmendoBio’s novel nuclease discovery platform broadens the targetable range of the genome while its target-specific optimization platform enables highly precise editing, including allele …
Ca.finance.yahoo.comDA: 20 PA: 50 MOZ Rank: 36
Emendo Biotherapeutics Company Profile: Acquisition & Investors
Emendo Biotherapeutics General Information. Description. Developer of gene editing tools designed to resolve bottlenecks in gene therapy. The company's tools uses protein engineering to bring disruptive protein process to resolve the bottleneck in gene therapy, enabling physicians to address disorders and diseases that are currently considered to be untreatable.
Pitchbook.comDA: 13 PA: 27 MOZ Rank: 55
Emendo Biotherapeutics CEO and key executive team | Craft.co
Emendo Biotherapeutics's President & Chief Executive Officer, Director is David Baram. Other executives include Todd Wider, Chairman of the Board & Chief Medical Officer; Christine Silverstein, CFO. See the full leadership team at Craft.
Craft.coDA: 8 PA: 34 MOZ Rank: 58
VIVEbiotech collaborates with Emendo Biotherapeutics
EmendoBio, created in 2015 and with its headquarters in New York and research laboratories in Israel, develops gene therapies for diseases of genetic origin. They are currently developing programs for hematology, ophthalmology, dermatology and oncology. VIVEbiotech will manufacture the batches for Emendo in its new facilities in San Sebastián, facilities that will …
Vivebiotech.comDA: 19 PA: 50 MOZ Rank: 33
Emendo Biotherapeutics to Present New Data at 63rd ASH Annual …
EmendoBio is a next generation CRISPR gene editing company leveraging dual proprietary technology platforms to enable high precision gene editing throughout the genome. EmendoBio’s novel nuclease discovery platform broadens the targetable range of the genome while its target-specific optimization platform enables highly precise editing ...
Ca.finance.yahoo.comDA: 20 PA: 50 MOZ Rank: 99
Emendo Biotherapeutics Nabs $61M for “Next-Generation …
Xconomy New York —. [ Updated 1/22/20120, 7:17 a.m. See below.] Emendo Biotherapeutics, a company aiming to apply CRISPR gene editing to a wider range of genetic diseases, has raised $61 million ...
Xconomy.comDA: 11 PA: 50 MOZ Rank: 31
Domains Expiration Date Updated
Site | Provider | Expiration Date |
---|---|---|
wifi-calling.com | namebright.com | 316 Days |
synproproducts.com | ionos.com | 159 Days |
binlocation.com | srsplus.com | 360 Days |
snuggle-up.com | godaddy.com | 296 Days |
bikeprovo.org | whois.godaddy.com | 49 Days |
dlmcjm.com | networksolutions.com | 77 Days |
green-pay.us | whois.godaddy.com | 113 Days |